EUFETS, now BioNTech IMFS, celebrates twenty years of uninterrupted service to the cell and gene therapy community. When our company was founded in 1997 with only seven employees, we could hardly foresee our growth to an international company with a staff of 160 within twenty years. With all the ups and downs in gene therapy, we could not have come this far without the loyal support and hard work of each member of our team.
To date, we have developed into a first-class address in developing and providing GMP manufacturing solutions for many corporate and academic clients in the CGT field in the national and international market.
On the occasion of our company anniversary, all of us at BioNTech IMFS would like to thank our business partners that have accompanied us on our successful path. And a very special thanks, of course, is to our customers for their longstanding loyalty and confidence in our capabilities and services.
Under our new name BioNTech IMFS, we want to continue being a competent partner and available in the field of CGT and contribute to our client’s market success with reliable and innovative manufacturing solutions.
